{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:44:11Z","timestamp":1785545051586,"version":"3.56.0"},"reference-count":50,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Cardio"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Home blood pressure telemonitoring (HBPT) has been proposed to enhance adherence and optimize health care delivery, yet its prerequisites for cost-effective implementation remain unclear.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aims to quantify the potential cost-effectiveness of HBPT and identify prerequisites for cost-effective implementation of HBPT in comparison to standard hypertension management, using an early health economic analysis from a societal perspective.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A decision-analytic Markov model with a lifetime horizon (30 years) and a willingness-to-pay threshold of \u20ac20,000 (\u20ac1=US $1.09) per quality-adjusted life year (QALY) was developed to assess the cost-effectiveness of HBPT compared to standard of care (SOC). The HBPT intervention was based on an existing HBPT program applied by the Maasstad Hospital, Rotterdam, the Netherlands. The model incorporated 12 health states: 7 blood pressure states, 1 cardiovascular (CV) event, 1 recurrent CV event, 1 postrecurrent CV event, 1 all-cause death, and 1 CV disease\u2013related death. A hypothetical cohort of 1000 patients (average age 65.3 years) was modeled, and results were reported in costs, QALYs, and the incremental cost-effectiveness ratio (ICER). The model assumed 3 in-person outpatient department (OPD) consultations in the SOC group and 1.5 in the HBPT group. Extensive sensitivity analyses were performed to identify important variables for the cost-effective implementation of HBPT.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Following the base-case analysis, HBPT was not cost-effective with an ICER of \u20ac20,386 per QALY. Sensitivity analyses indicated that reducing the number of in-person OPD consultations resulted in a more favorable ICER. Specifically, reducing the number of in-person OPD consultations to 1.48 annually resulted in an ICER below the willingness-to-pay threshold. Reducing the in-person OPD consultations to an average of 1.18 per year would make HBPT cost-saving. Scenario analyses revealed that extending the duration of HBPT\u2019s clinical effect to 2 or 3 years substantially improved the ICER. Additionally, targeting HBPT toward patients aged 64 years or below further improved the ICER.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n HBPT could result in cost-effective or cost-saving outcomes with only minor reductions in in-person OPD consultations. These findings highlight the potential of HBPT to transform hypertension management by replacing traditional hypertension management with more efficient care using remote patient monitoring.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/64386","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:46:30Z","timestamp":1746726390000},"page":"e64386-e64386","source":"Crossref","is-referenced-by-count":1,"title":["Prerequisites for Cost-Effective Home Blood Pressure Telemonitoring: Early Health Economic Analysis"],"prefix":"10.2196","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5062-5397","authenticated-orcid":false,"given":"Job","family":"van Steenkiste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8401-0932","authenticated-orcid":false,"given":"Pim","family":"van Dorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1738-914X","authenticated-orcid":false,"given":"Daan","family":"Dohmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1190-2638","authenticated-orcid":false,"given":"Cornelis","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"issue":"2","key":"R1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","article-title":"High blood pressure and cardiovascular disease","volume":"75","author":"Fuchs","journal-title":"Hypertension"},{"issue":"5","key":"R2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/sj.jhh.1001672","article-title":"Prevalence and determinants of undertreatment of hypertension in the Netherlands","volume":"18","author":"Schelleman","journal-title":"J Hum Hypertens"},{"issue":"7","key":"R3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/jhh.2016.99","article-title":"Effectiveness of home blood pressure telemonitoring: a systematic review and meta-analysis of randomised controlled studies","volume":"31","author":"Duan","journal-title":"J Hum Hypertens"},{"issue":"8","key":"R4","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1111\/bcp.16125","article-title":"\u201cUnder pressure\u201d: the role of therapeutic drug monitoring in the treatment of hypertension","volume":"90","author":"Versmissen","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"R5","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/jch.13305","article-title":"Home blood pressure telemonitoring in the 21st century","volume":"20","author":"Parati","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R6","unstructured":"Luscii. URL: https:\/\/luscii.com\/en\/home [Accessed 12-7-2024]"},{"key":"R7","unstructured":"Patient Journey App. URL: https:\/\/patientjourneyapp.com [Accessed 12-7-2024]"},{"issue":"4","key":"R8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/ehjdh\/ztac049","article-title":"Automatic transmission of home blood pressure data can be effective in managing hypertension: a systematic review and meta-analysis","volume":"3","author":"Kaihara","journal-title":"Eur Heart J Digit Health"},{"issue":"4","key":"R9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-057494","article-title":"Enablers and barriers in upscaling telemonitoring across geographic boundaries: a scoping review","volume":"12","author":"Gijsbers","journal-title":"BMJ Open"},{"issue":"1","key":"R10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/jac5.1001","article-title":"Economic evaluation of the home blood pressure telemonitoring and pharmacist case management to control hypertension (Hyperlink) trial","volume":"1","author":"Dehmer","journal-title":"J Am Coll Clin Pharm"},{"issue":"5","key":"R11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002681","article-title":"Telemonitoring-based service redesign for the management of uncontrolled hypertension (HITS): cost and cost-effectiveness analysis of a randomised controlled trial","volume":"3","author":"Stoddart","journal-title":"BMJ Open"},{"issue":"3","key":"R12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/HJH.0b013e32835ca8dd","article-title":"Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies","volume":"31","author":"Omboni","journal-title":"J Hypertens"},{"key":"R13","unstructured":"Yee M Tappenden P Wailoo A . NICE DSU report: economic evaluation in NICE early value assessments. The University of Sheffield; 2023. URL: https:\/\/www.sheffield.ac.uk\/nice-dsu\/methods-development\/eva [Accessed 15-04-2025]"},{"issue":"6","key":"R14","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1524-4733.2010.00736.x","article-title":"Quantification of the potential impact of cost-effectiveness thresholds on Dutch drug expenditures using retrospective analysis","volume":"13","author":"Boersma","journal-title":"Value Health"},{"key":"R15","unstructured":"Guideline for conducting health economic evaluations [Report in Dutch]. Dutch Healthcare Institute; 2024. URL: https:\/\/www.zorginstituutnederland.nl\/publicaties\/publicatie\/2024\/01\/16\/richtlijn-voor-het-uitvoeren-van-economische-evaluaties-in-de-gezondheidszorg [Accessed 12-07-2024]"},{"key":"R16","unstructured":"Consumer price indexation [Web page in Dutch]. Central Statistics Office. URL: https:\/\/opendata.cbs.nl\/statline\/#\/CBS\/nl\/dataset\/70936NED\/table?fromstatweb [Accessed 18-07-2024]"},{"key":"R17","unstructured":"R: a language and environment for statistical computing. R Foundation for Statistical Computing. URL: https:\/\/www.R-project.org [Accessed 15-04-2025]"},{"issue":"10285","key":"R18","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","journal-title":"Lancet"},{"issue":"7","key":"R19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028762","article-title":"Stage 1 hypertension and the 10-year and lifetime risk of cardiovascular disease: a prospective real-world study","volume":"12","author":"Peng","journal-title":"J Am Heart Assoc"},{"issue":"16","key":"R20","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1136\/heartjnl-2021-320171","article-title":"Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials","volume":"108","author":"Canoy","journal-title":"Heart"},{"issue":"2","key":"R21","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.118.12191","article-title":"Prevalence of apparent treatment-resistant hypertension in the United States","volume":"73","author":"Carey","journal-title":"Hypertension"},{"key":"R22","unstructured":"Age-based mortality [Web page in Dutch]. Central Statistics Office. URL: https:\/\/www.cbs.nl\/nl-nl\/cijfers\/detail\/37360ned [Accessed 12-07-2024]"},{"issue":"19","key":"R23","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1161\/CIRCULATIONAHA.116.021314","article-title":"Distribution of estimated 10-year risk of recurrent vascular events and residual risk in a secondary prevention population","volume":"134","author":"Kaasenbrood","journal-title":"Circulation"},{"issue":"12","key":"R24","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia","journal-title":"J Hypertens"},{"key":"R25","unstructured":"Dbc-pakket 2024 rz24a [Web page in Dutch]. Dutch Healthcare Authority. Jul12, 2024. URL: https:\/\/puc.overheid.nl\/nza\/doc\/PUC_740006_22\/1\/ [Accessed 16-04-2025]"},{"key":"R26","unstructured":"Telemonitoring and e-coaching in hypertension. ClinicalTrials.gov. URL: https:\/\/clinicaltrials.gov\/study\/NCT05660226 [Accessed 12-07-2024]"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2018.02.033","article-title":"Cost-effectiveness analysis of intensive hypertension control in China","volume":"111","author":"Xie","journal-title":"Prev Med"},{"issue":"1","key":"R28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12955-020-01407-y","article-title":"Utility value estimates in cardiovascular disease and the effect of changing elicitation methods: a systematic literature review","volume":"18","author":"Betts","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"R29","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1270","article-title":"Quality of life and depression 3 months after intracerebral hemorrhage","volume":"9","author":"Sallinen","journal-title":"Brain Behav"},{"issue":"8","key":"R30","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1177\/2047487318817910","article-title":"Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: an Australian healthcare perspective","volume":"26","author":"Zomer","journal-title":"Eur J Prev Cardiol"},{"key":"R31","unstructured":"IHealth track blood pressure machine [Web page in Dutch]. Bol. URL: https:\/\/www.bol.com\/nl\/nl\/p\/ihealth-track-kn-550bt-bloeddrukmeter-bovenarm-hartstichting-klinisch-gevalideerd-hartslagmeter-bluetooth-smartphone-app-onregelmatige-hartslag-geheugen-gemiddelde-laatste-3-metingen-who-stoplicht-indicator-manchet-22-42-cm\/9200000061056044\/?bltgh=tXYw2la61G4fI9ZABXRFBQ.4_27.28.ProductImage [Accessed 12-07-2024]"},{"key":"R32","unstructured":"Digital health reimbursement 2024 [Web page in Dutch]. Dutch Healthcare Authority. URL: https:\/\/puc.overheid.nl\/nza\/doc\/PUC_655318_22\/1 [Accessed 12-07-2024]"},{"key":"R33","unstructured":"Pharmaceutical care integral funding [Report in Dutch]. Netherlands Institute for Health Services Research; 2011. URL: https:\/\/www.nivel.nl\/sites\/default\/files\/bestanden\/Rapport-Farmaceutische-zorg-integrale-bekostiging.pdf [Accessed 12-07-2024]"},{"issue":"11","key":"R34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008220","article-title":"The burden of stroke in the Netherlands: estimating quality of life and costs for 1 year poststroke","volume":"5","author":"van Eeden","journal-title":"BMJ Open"},{"issue":"5","key":"R35","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12471-013-0386-y","article-title":"Treatment costs of acute myocardial infarction in the Netherlands","volume":"21","author":"Soekhlal","journal-title":"Neth Heart J"},{"key":"R36","unstructured":"Cost manual for economic evaluations in healthcare: methodology and reference prices [Web page in Dutch]. Dutch Healthcare Institute. URL: https:\/\/www.zorginstituutnederland.nl\/over-ons\/werkwijzen-en-procedures\/adviseren-over-en-verduidelijken-van-het-basispakket-aan-zorg\/beoordeling-van-geneesmiddelen\/richtlijn-voor-economische-evaluatie [Accessed 12-07-2024]"},{"key":"R37","unstructured":"Absence due to physical conditions in a working population [Web page in Dutch]. Trimbos Institute. URL: https:\/\/www.trimbos.nl\/docs\/af1092-verzuim-door-psychische-en-somatische-aandoeningen-bij-werkenden.pdf [Accessed 12-07-2024]"},{"key":"R38","unstructured":"Labor participation in the Netherlands [Web page in Dutch]. Central Statistics Office. URL: https:\/\/www.cbs.nl\/nl-nl\/visualisaties\/dashboard-arbeidsmarkt\/werkenden#:~:text=De%20werkzame%20beroepsbevolking%20bestaat%20uit,in%20het%20buitenland%20werkzaam%20zijn [Accessed 12-07-2024]"},{"key":"R39","unstructured":"Average hourly wage in the Netherlands [Web page in Dutch]. Central Statistics Office. URL: https:\/\/www.cbs.nl\/nl-nl\/visualisaties\/dashboard-arbeidsmarkt\/ontwikkeling-cao-lonen\/uurloon#:~:text=Als%20we%20kijken%20naar%20gemiddelden,van%2028%20euro%20of%20hoger [Accessed 12-07-2024]"},{"key":"R40","unstructured":"Quality of health measurements [Web page in Dutch]. Dutch Healthcare Institute. URL: https:\/\/www.zorginstituutnederland.nl\/binaries\/zinl\/documenten\/publicatie\/2024\/01\/16\/richtlijn-voor-het-uitvoeren-van-economische-evaluaties-in-de-gezondheidszorg\/Verdiepingsmodule+QALY+en+kwaliteit-van-leven-metingen+%28versie+2024%29.pdf [Accessed 12-07-2024]"},{"key":"R41","unstructured":"DHI amlodipine drug costs [Web page in Dutch]. Dutch Healthcare Institute. URL: https:\/\/www.medicijnkosten.nl\/zoeken?trefwoord=amlodipine [Accessed 18-07-2024]"},{"key":"R42","unstructured":"Average working week in the Netherlands [Web page in Dutch]. Central Statistics Office. URL: https:\/\/www.cbs.nl\/nl-nl\/nieuws\/2020\/08\/meer-dan-de-helft-werkt-voltijds [Accessed 12-07-2024]"},{"key":"R43","unstructured":"Guideline for the treatment of patients with severe hypertension [Web page in Dutch]. KvK Federation of Medical Specialists. URL: https:\/\/richtlijnendatabase.nl\/richtlijn\/hypertensief_spoedgeval\/behandeling_van_ernstige_hypertensie_zonder_acute_orgaanschade.html [Accessed 12-07-2024]"},{"issue":"8","key":"R44","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1001\/jama.2014.10057","article-title":"Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial","volume":"312","author":"McManus","journal-title":"JAMA"},{"issue":"1","key":"R45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40273-021-01070-1","article-title":"The challenges of outcomes-based contract implementation for medicines in Europe","volume":"40","author":"Bohm","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"R46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/jch.13459","article-title":"Cost-effectiveness of home blood pressure telemonitoring and case management in the secondary prevention of cerebrovascular disease in Canada","volume":"21","author":"Padwal","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"R47","doi-asserted-by":"publisher","DOI":"10.2196\/31302","article-title":"Home telemonitoring and a diagnostic algorithm in the management of heart failure in the Netherlands: cost-effectiveness analysis","volume":"6","author":"Albuquerque de Almeida","journal-title":"JMIR Cardio"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.2196\/51841","article-title":"Effectiveness of telemonitoring in reducing hospitalization and associated costs for patients with heart failure in Finland: nonrandomized pre-post telemonitoring study","volume":"12","author":"Kokkonen","journal-title":"JMIR Mhealth Uhealth"},{"issue":"3","key":"R49","doi-asserted-by":"publisher","DOI":"10.2196\/26516","article-title":"Cost-effectiveness of a telemonitoring program for patients with heart failure during the COVID-19 pandemic in Hong Kong: model development and data analysis","volume":"23","author":"Jiang","journal-title":"J Med Internet Res"},{"key":"R50","volume":"165","author":"van Herwerden","journal-title":"Ned Tijdschr Geneeskd"}],"container-title":["JMIR Cardio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cardio.jmir.org\/2025\/1\/e64386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:30:28Z","timestamp":1785537028000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardio.jmir.org\/2025\/1\/e64386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":50,"URL":"https:\/\/doi.org\/10.2196\/64386","relation":{},"ISSN":["2561-1011"],"issn-type":[{"value":"2561-1011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"article-number":"v9i2e64386"}}